ENLV
Enlivex Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.37
−5.92%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
105.4%
Return on equity
83.8%
Return on assets
-0.5%
Return on invested capital
0.00x
Asset turnover
-$15.8M
Cash from operations
$3.60
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026